Direxion Daily S&P Biotech Bull 3X Shares 

$176.25
194
+$10.39+6.26% Monday 21:00

Statistics

Day High
176.87
Day Low
163.08
52W High
198.18
52W Low
32.55
Volume
497,604
Avg. Volume
718,729
Mkt Cap
0
P/E Ratio
-
Dividend Yield
1.28%
Dividend
2.25

Upcoming

Dividends

1.28%Dividend Yield
Dec 25
$0.91
Sep 25
$0.1
Jul 25
$0.22
Apr 25
$0.11
Jul 24
$0.15
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
46.73%
1Y Growth
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LABU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Direxion Daily S&P Biotech Bear 3X Shares
LABD
Mkt Cap0
Direxion Daily S&P Biotech Bear 3X Shares, the inverse ETF of LABU, offering 3X leveraged exposure in the opposite direction.
ProShares Ultra Nasdaq Biotechnology 2X Shares
BIB
Mkt Cap0
ProShares Ultra Nasdaq Biotechnology, a 2X leveraged ETF focusing on the biotech sector, similar to LABU but with less leverage.
ProShares UltraShort Nasdaq Biotechnology -2x Shares
BIS
Mkt Cap0
ProShares UltraShort Nasdaq Biotechnology, offers 2X leveraged inverse exposure to the biotech sector, competing with LABU's bear counterpart.
State Street SPDR S&P Biotech
XBI
Mkt Cap0
SPDR S&P Biotech ETF, a non-leveraged ETF that tracks the biotech sector, competing for the same investor base as LABU.
iShares Biotechnology
IBB
Mkt Cap0
iShares Nasdaq Biotechnology ETF, another major non-leveraged biotech ETF, competing in the biotech investment space with LABU.
VanEck Biotech
BBH
Mkt Cap0
VanEck Vectors Biotech ETF, offers exposure to the biotech industry, competing with LABU for biotech-focused investments.
First Trust NYSE Arca Biotechnology Index Fund
FBT
Mkt Cap0
First Trust NYSE Arca Biotechnology Index Fund, a non-leveraged ETF competing in the biotech sector investment space.
ALPS Medical Breakthroughs
SBIO
Mkt Cap0
ALPS Medical Breakthroughs ETF, focuses on smaller companies in the biotech sector, offering a different approach but still competing for biotech investors.
ARK Genomic Revolution
ARKG
Mkt Cap0
ARK Genomic Revolution ETF, focuses on genomics and biotech, competing with LABU by targeting innovation in the biotech space.
Invesco Biotechnology & Genome
PBE
Mkt Cap0
Invesco Dynamic Biotechnology & Genome ETF, offers exposure to the biotech and genomic sector, competing for similar investment interests.

About

The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Show more...
CEO
Country
US
ISIN
US25460G1206

Listings

0 Comments

Share your thoughts

FAQ

What is Direxion Daily S&P Biotech Bull 3X Shares stock price today?
The current price of LABU is $176.25 USD — it has increased by +6.26% in the past 24 hours. Watch Direxion Daily S&P Biotech Bull 3X Shares stock price performance more closely on the chart.
What is Direxion Daily S&P Biotech Bull 3X Shares stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Direxion Daily S&P Biotech Bull 3X Shares stocks are traded under the ticker LABU.
Is Direxion Daily S&P Biotech Bull 3X Shares stock price growing?
LABU stock has fallen by -3.1% compared to the previous week, the month change is a +11.9% rise, over the last year Direxion Daily S&P Biotech Bull 3X Shares has showed a +91.91% increase.
Does Direxion Daily S&P Biotech Bull 3X Shares pay dividends?
Yes, LABU dividends are paid quarterly. The last dividend per share was 0.91 USD. As of today, Dividend Yield (FWD)% is 1.28%.
When did Direxion Daily S&P Biotech Bull 3X Shares complete a stock split?
The last stock split for Direxion Daily S&P Biotech Bull 3X Shares was on December 04, 2023 with a ratio of 1:20.